Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Lilly Del Caribe, Inc. (PR02) Carolina US

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for R1-CEP 1996-073 - Rev 02 of Lilly Del Caribe, Inc. (pr02) Carolina Us

Looking for Certificates of Suitability (CEPs) for R1-CEP 1996-073 - Rev 02 of Lilly Del Caribe, Inc. (pr02) Carolina Us 1

20

Lilly Del Caribe, Inc. (pr02) Carolina Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Tobramycin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1996-073 - Rev 02

This Chemical Type CEP, issued on March 20, 2007, remains in force until June 06, 2013, ensuring its reliability within the pharmaceutical industry.

Substance Number 645 associated with this CEP further emphasizes